Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers

Onkologie

Volumn 34, Issue 8-9, 2011, Pages 422-426

  Prasad, Vidudala V T S ^a   Wilkhoo, Harpreet ^a  

^a BASAVATARAKAM INDO AMERICAN CANCER HOSPITAL AND RESEARCH INSTITUTE   (India)

Author keywords

Cervical cancer; Colorectal cancer; MTHFR; Ovarian cancer; Polymorphism; Thyroid cancer

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GENOMIC DNA;

ALLELE; ARTICLE; BREAST CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OVARY CANCER; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THYROID CANCER; UTERINE CERVIX CANCER;

ALLELES; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OVARIAN NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROID NEOPLASMS; UTERINE CERVICAL NEOPLASMS;

EID: 80053243541     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000331131     Document Type: Article

References (57)

1. Wagner C: Biochemical role of folate in cellular metabolism; in Bailey LB (ed): Folate in Health and Disease. New York, NY, Marcel Dekker Inc., 1995, pp. 23-42.
2. Choi SW, Mason JB: Folate status: Effects on pathways of colorectal carcinogenesis. J Nutr 2002;132:2413S-2418S.
3. Panigrahi I, Chatterjee T, Biswas A, Behari M, Choudhry PV, Saxena R: Role of MTHFR C677T polymorphism in ischemic stroke. Neurol India 2006;54:48-52.
4. Sauer J, Mason JB, Choi S-W: Too much folate - a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 2009;12:30-36.
5. Parle-McDermott A, Mills JL, Molloy AM, Carroll N, Kirke PN, Cox C, Conley MR, Pangilinan FJ, Brody LC, Scott JM: The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab 2006;88:290-294. (Pubitemid 43977813)
6. Rosenberg N, Murata M, Ikeda Y, Opare-Sem O, Zivelin A, Geffen E, Seligsohn U: The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in Whites, Japanese, and Africans. Am J Hum Genet 2002;70:758-762. (Pubitemid 34177929)
7. Rama Devi AR, Govindaiah V, Ramakrishna G, Naushad SM: Prevalence of methylene tetrahydrofolate reductase polymorphism in South Indian population. Curr Sci 2004;86:440-443. (Pubitemid 39160285)
8. Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W: Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 2003;18: 1535-1540. (Pubitemid 36939625)
9. Larsson SC, Giovannucci E, Wolk A: Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: A meta-analysis. Gastroenterology 2006;131:1271-1283. (Pubitemid 44515102)
10. Marchand LL, Wilkens LR, Kolonel LN, Henderson BE: The MTHFR C677T polymorphism and colorectal cancer: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2005; 14:1198-1203. (Pubitemid 40656467)
11. Chou Y-C, Wu M-H, Yu J-C, Lee M-S, Yang T, Shih H-L, Wu T-Y, Sun C-A: Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels, and breast cancer susceptibility: A case-control study in Taiwan. Carcinogenesis 2006;27:2295-2300. (Pubitemid 44644819)
12. Shekari M, Sobti RC, Tamandani DMK, Suri V: Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 2008;278:517-524.
13. Zintzaras E: Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: A meta-analysis. J Hum Genet 2006;51:618-624. (Pubitemid 44048695)
14. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U: Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat 2007;104:299-308. (Pubitemid 47231276)
15. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K: One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008;29:356-362. (Pubitemid 351359675)
16. Rao GG, Kurien A, Gossett D, Griffith WF, Coleman RL, Muller CY: A case-control study of methylenetetrahydrofolate reductase polymorphisms in cervical carcinogenesis. Gynecol Oncol 2006;101:250-254.
17. Ma E, Iwasaki M, Junko I, Hamada GS, Nishimoto IN, Carvalho SMT, Motola J Jr, Laginha FM, Tsugan S: Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: A case-control study in Brazilian women. BMC Cancer 2009;9:122.
18. Terry KL, Tworoger SS, Goode EL, Gates MA, Titus-Ernstoff L, Kelemen LE, Sellers TA, Hankinson SE, Cramer DW: MTHFR polymorphisms in relation to ovarian cancer risk. Gynecol Oncol 2010;119:319-324.
19. Miller S, Dykes D, Polesky H: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
20. Asher RE, Moseley C: Atlas of the World's Languages. London, Routledge (Taylor and Francis), 2007.
21. Fard-Esfahani P, Fard-Esfahani A, Saidi P, Fayaz S, Mohabati R, Majdi M: An increased risk of differentiated thyroid carcinoma in Iran with the 677C>T homozygous polymorphism in the MTHFR gene. Cancer Epidemiol 2011;35:56-58.
22. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM: Colorectal cancer and the methylenetetrahydrofolate reductase 677C?T and methionine synthase 2756A?G polymorphisms: A study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev 2004; 13:2175-2180. (Pubitemid 40054314)
23. Zhang W, Press OA, Haiman CA, Yang DY, et al.: Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer. J Clin Oncol 2007;25:3726-3731. (Pubitemid 47372614)
24. Rijnsoever MV, Grieu F, Elsaleh H, Joseph D, Iacopetta B: Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 2002;51:797-802. (Pubitemid 35408598)
25. Lima CSP, Nascimento H, Bonadia LC, Teori MT, Coy CSR, Goes JR, Costa FF, Bertuzzo CS, et al.: Polymorphisms in methylenetetrahydrofolate reductase gene (MTHFR) and the age of onset of sporadic colorectal adenocarcinoma. Int J Colorecal Dis 2007;22:757-763. (Pubitemid 46876192)
26. El Awady MK, Karim AM, Hanna LS, El Husseiny LA, El Sahar M, Menem HA, Meguid NA: Methylenetetrahydrofolate reductase gene polymorphisms and the risk of colorectal carcinoma in a sample of Egyptian individuals. Cancer Biomark 2009;5:233-240.
27. Chandy S, Adiga MNS, Ramachandra N, Krishnamoorthy S, Ramaswamy G, Savithri HS, Krishnamoorthy L: Association of methylenetetrahydrofolate reductase gene polymorphisms & colorectal cancer in India. Indian J Med Res 2010;131:659-664.
28. Cui L-H, Shin M-H, Kweon S-S, Kim HN, Song HR, Piao J-M, Choi J-S, Shim HJ, Hwang JE, Kim H-R, Park Y-K, Kim S-H: Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer 2010;10:236.
29. Osian G, Procopciuc L, Vlad L, Iancu C, Mocan T, Mocan L: C677T and A1298C Mutations in the MTHFR gene and survival in colorectal cancer. J Gastrointestin Liver Dis 2009;18:455-460.
30. Yin G, Kono S, Toyomura K, Hagiwara T, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Yasunami Y, Maekawa T, Takenaka K, Ichimiya H, Imaizumi N: Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: The Fukuoka colorectal cancer study. Cancer Sci 2004;95:908-913. (Pubitemid 40045526)
31. Kono S, Chen K: Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci 2005;96:535-342.
32. Wang J, Gajalakshmi V, Jiang J, Kuriki K, Susuki S, Nagaya T, Nakamura S, Akasaka S, Ishikawa H, Tokudome S: Associations between 5, 10- methylenetetrahydrofolate reductase codon 677 and 1298 genetic polymorphisms and environmental factors with reference to susceptibility to colorectal cancer: A case-control study in an Indian population. Int J Cancer 2006;118:991-997. (Pubitemid 43157676)
33. Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V,Baisch C, Vollmert C, Illig T, Brüning T, Ko Y, Brauch H: One-carbon metabolism and breast cancer risk: No association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev 2005;14:3015-3018. (Pubitemid 43068843)
34. Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, Yoo KY, Ahn SH, Choe KJ, Hirvonen A, Noh DY: Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 2004;36:116-121. (Pubitemid 38667919)
35. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hébert JR, Jin F, Zheng W: MTHFR polymorphisms, dietary folate intake, and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2004; 13:190-196. (Pubitemid 38222548)
36. Chen J, Gammon MD, Chan W, Palomeque C, et al.: One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005;65:1606-1614. (Pubitemid 40270191)
37. Maruti SS, Ulrich CM, Jupe ER, White E: MTHFR C677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: A nested case-control study. Breast Cancer Res 2009;11:R91.
38. Campbell IG, Baxter SW, Eccles DM, Choong DYH: Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 2002;4:R14.
39. Piyathilake CJ, Macaluso M, Johanning GL, Whiteside M, Heimburger DC, Giuliano A: Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 2000; 20:1751-1757. (Pubitemid 30628198)
40. Magnowski P, Seremak-Mrozikiewicz A, Nowak- Markwitz E, Kurzawinska G, Drews K, Spaczynski M: No association between MTHFR 677C>T polymorphism and ovarian cancer risk in BRCA1 mutation carriers in Wielkopolska region. Ginekol Pol 2010;81:506-510.
41. Schneider JA, Rees DC, Liu YT, Clegg JB: Worldwide distribution of a common methylenetetrahydrofolate reductase mutation. Am J Hum Genet 1998;62:1258-1260. (Pubitemid 28199029)
42. Angeline T, Jeyaraj N, Granito S, Tsongalis GJ: Prevalence of MTHFR gene polymorphisms (C677T and A1298C) among Tamilians. Exp Mol Pathol 2004;77:85-88. (Pubitemid 39209289)
43. Singh K, Singh SK, Sah R, Singh I, Raman R: Mutation C677T in the methylenetetrahydrofolate reductase gene is associated with male infertility in an Indian population. Int J Androl 2005;28:115-119. (Pubitemid 40461182)
44. Saraswathy KN, Mukhopadhyay R, Sinha E, Aggarwal S, Sachdeva MP, Kalla AK: MTHFR C677T polymorphisms among the Ahirs and Jats of Haryana (India). Am J Hum Biol 2008;20:116-117.
45. Cyril C, Rai P, Chandra N, Gopinath PM, Satyamoorthy K: MTHFR Gene variants C677T, A1298C and association with Down syndrome: A case-control study from South India. Indian J Hum Genet 2009;15:60-64.
46. Bhat TA, Mir MR, Qasim I, Misra SS, Kirmani MA: Genetic polymorphism of 5, 10-methylenetetrahydrofolate reductase C677T in Kashmiri population. Biotechnology 2008;7:822-825.
47. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, et al.: Geographical and ethnic variation of the 677 C?T allele of 5,10-MTHFR: Findings from over 7,000 newborns from 16 areas world wide. J Med Genet 2003;40:619-625. (Pubitemid 37046918)
48. Zijno A, Andreoli C, Leopardi P, Marcon F, Rossi S, Caiola S, Verdina A, Galati R, Cafolla A, Crebelli R: Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects. Carcinogenesis 2003;24:1097-1103. (Pubitemid 36827262)
49. Chango A, Potier DCG, Boisson F, Guilland JC, Barbe F, Perrin MO, Christidés JP, Rabhi K, Pfister M, Galan P, Hercberg S, Nicolas JP: 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the supplementation en Vitamins at Mineraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr 2000;84:891-896. (Pubitemid 32106814)
50. Krajinovic M, Lamoha S, Labuda DE, Milie LB, Theoret Y, Moghrabi A, Sinnett D: Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004;103:252-257. (Pubitemid 38029946)
51. Gao W, Wang Y, Zhang P, Wang H: MTHFR C677T mutation in central retinal vein occlusion; a case-control study in Chinese population. Thromb Res 2008;121:699-703. (Pubitemid 351305289)
52. Morita H, Taguchi J, Kurihara H, Kitaoka M, et al.: Genetic polymorphism of 5,10 methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997;95: 2032-2036. (Pubitemid 27184270)
53. Chambers JC, Ireland H, Thompson E, Reilly P, et al.: Methylenetetrahydrofolate reductase 677 C?T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 2000;20:2448-2452.
54. Ranjith N, Pegoraro RJ, Rom L: Risk factors and methylenetetrahydrofolate reductase gene polymorphisms in a young South African Indian-based population with acute myocardial infarction. Cardiovasc J S Afr 2003;14:127-132. (Pubitemid 37010267)
55. Sohn K-J, Croxford R, Yates Z, Lucock M, Kim Y-I: Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 2004;96:134-144. (Pubitemid 38195904)
56. Gusella M, Frigo AC, Bolzonella C, Marinelli R, et al.: Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. Br J Cancer 2009;100:1549-1557.
57. Wettergren Y, Odin E, Carlsson G, Gustavsson B: MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer. Mol Med 2010;16:425-432.